"Immunocompromised Host" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
| Descriptor ID |
D016867
|
| MeSH Number(s) |
G12.470
|
| Concept/Terms |
Immunocompromised Host- Immunocompromised Host
- Host, Immunocompromised
- Hosts, Immunocompromised
- Immunocompromised Hosts
- Immunocompromised Patient
- Immunocompromised Patients
- Patient, Immunocompromised
- Patients, Immunocompromised
- Immunosuppressed Host
- Host, Immunosuppressed
- Hosts, Immunosuppressed
- Immunosuppressed Hosts
|
Below are MeSH descriptors whose meaning is more general than "Immunocompromised Host".
Below are MeSH descriptors whose meaning is more specific than "Immunocompromised Host".
This graph shows the total number of publications written about "Immunocompromised Host" by people in this website by year, and whether "Immunocompromised Host" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 3 | 0 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 3 | 3 | 6 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 4 | 6 |
| 2008 | 1 | 3 | 4 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 4 | 6 |
| 2011 | 0 | 2 | 2 |
| 2012 | 2 | 3 | 5 |
| 2013 | 0 | 3 | 3 |
| 2014 | 4 | 2 | 6 |
| 2015 | 0 | 7 | 7 |
| 2016 | 7 | 8 | 15 |
| 2017 | 52 | 92 | 144 |
| 2018 | 61 | 93 | 154 |
| 2019 | 33 | 59 | 92 |
| 2020 | 42 | 80 | 122 |
| 2021 | 43 | 52 | 95 |
| 2022 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunocompromised Host" by people in Profiles.
-
T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Feb 23; 16(2):251-258.
-
Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs. Clin Infect Dis. 2022 02 11; 74(3):553.
-
COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm. 2022 01 05; 79(2):63-71.
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
-
Low mortality in SARS-CoV-2 infected heart transplant recipients at a single center. Clin Transplant. 2022 01; 36(1):e14443.
-
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients. Transplantation. 2021 12 01; 105(12):e282.
-
Clinical Outcomes and Antibody Response in COVID-19-Positive Pediatric Solid Organ Transplant Recipients. Pediatr Infect Dis J. 2021 12 01; 40(12):e514-e516.
-
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients. Curr Opin Hematol. 2021 11 01; 28(6):394-400.
-
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients. Transplantation. 2021 11 01; 105(11):e226-e233.
-
Confronting the Delta Variant of SARS-CoV-2, Summer 2021. JAMA. 2021 Sep 21; 326(11):1001-1002.